Event

Ryan Owen

PhD
Genentech, Inc.

Janusz Kaminski

MD, PhD
Roche Products Ltd

Jeffrey J. Swigris

DO, MS
Autoimmune Lung Ctr & Interstitial Lung Disease Program;National Jewish Health;Natl Jewish Hlth

Ian Glaspole

MD, PhD
Alfred Hospital;Alfred Hospital and Monash University

David Kardatzke

PhD
Genentech, Inc.

Toby M. Maher

MD, MSc, PhD, FRCP
Imperial College;Imperial College London;Imperial College, London;National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Hare;Royal Brompton and Harefield NHS

Takashi Ogura

MD
Kanagawa Cardiovascular & Respiratory Ctr;Kanagawa Cardiovascular and Respiratory Center

Paula Belloni

PhD
Genentech, Inc.

Marcela Castro

MD
Genentech, Inc.

Mary Beth Scholand

MD
Univ of Utah;University of Utah

Margaret Neighbors

PhD
Genentech, Inc.

The RIFF Study (Cohort A): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab as Monotherapy in Patients with Idiopathic Pulmonary Fibrosis